nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—NCOA3—prostate cancer	0.358	0.775	CbGaD
Amsacrine—TOP2A—prostate cancer	0.104	0.225	CbGaD
Amsacrine—TOP2A—Mitoxantrone—prostate cancer	0.0589	0.188	CbGbCtD
Amsacrine—TOP2A—Epirubicin—prostate cancer	0.0477	0.152	CbGbCtD
Amsacrine—TOP2A—Etoposide—prostate cancer	0.0372	0.119	CbGbCtD
Amsacrine—TOP2A—Doxorubicin—prostate cancer	0.0253	0.0809	CbGbCtD
Amsacrine—CYP2D6—Bicalutamide—prostate cancer	0.0208	0.0666	CbGbCtD
Amsacrine—ABCB1—Estramustine—prostate cancer	0.0206	0.0657	CbGbCtD
Amsacrine—CYP2D6—Abiraterone—prostate cancer	0.0173	0.0551	CbGbCtD
Amsacrine—ABCB1—Cabazitaxel—prostate cancer	0.0136	0.0433	CbGbCtD
Amsacrine—ABCB1—Estrone—prostate cancer	0.0133	0.0423	CbGbCtD
Amsacrine—ABCB1—Ethinyl Estradiol—prostate cancer	0.0118	0.0377	CbGbCtD
Amsacrine—ABCB1—Conjugated Estrogens—prostate cancer	0.00867	0.0277	CbGbCtD
Amsacrine—ABCB1—Mitoxantrone—prostate cancer	0.00788	0.0252	CbGbCtD
Amsacrine—ABCB1—Estradiol—prostate cancer	0.00761	0.0243	CbGbCtD
Amsacrine—ABCB1—Prednisone—prostate cancer	0.00654	0.0209	CbGbCtD
Amsacrine—ABCB1—Etoposide—prostate cancer	0.00497	0.0159	CbGbCtD
Amsacrine—ABCB1—Docetaxel—prostate cancer	0.00455	0.0145	CbGbCtD
Amsacrine—ABCB1—Doxorubicin—prostate cancer	0.00339	0.0108	CbGbCtD
Amsacrine—CYP2D6—Doxorubicin—prostate cancer	0.00319	0.0102	CbGbCtD
Amsacrine—NCOA3—prostate gland—prostate cancer	0.00262	0.126	CbGeAlD
Amsacrine—NCOA3—renal system—prostate cancer	0.00178	0.0856	CbGeAlD
Amsacrine—NCOA3—urethra—prostate cancer	0.00175	0.084	CbGeAlD
Amsacrine—TOP2A—prostate gland—prostate cancer	0.00154	0.0736	CbGeAlD
Amsacrine—CYP2D6—urine—prostate cancer	0.00146	0.0701	CbGeAlD
Amsacrine—NCOA3—bone marrow—prostate cancer	0.00135	0.0647	CbGeAlD
Amsacrine—NCOA3—testis—prostate cancer	0.00115	0.0553	CbGeAlD
Amsacrine—KCNH2—prostate gland—prostate cancer	0.00086	0.0413	CbGeAlD
Amsacrine—NCOA3—lymph node—prostate cancer	0.000836	0.0401	CbGeAlD
Amsacrine—TOP2A—bone marrow—prostate cancer	0.000791	0.038	CbGeAlD
Amsacrine—KCNH2—seminal vesicle—prostate cancer	0.000728	0.0349	CbGeAlD
Amsacrine—TOP2A—testis—prostate cancer	0.000676	0.0324	CbGeAlD
Amsacrine—KCNH2—renal system—prostate cancer	0.000586	0.0281	CbGeAlD
Amsacrine—KCNH2—urethra—prostate cancer	0.000576	0.0276	CbGeAlD
Amsacrine—TOP2A—Docetaxel—Cabazitaxel—prostate cancer	0.000529	0.196	CbGdCrCtD
Amsacrine—TOP2A—lymph node—prostate cancer	0.00049	0.0235	CbGeAlD
Amsacrine—KCNH2—bone marrow—prostate cancer	0.000443	0.0213	CbGeAlD
Amsacrine—KCNH2—testis—prostate cancer	0.000379	0.0182	CbGeAlD
Amsacrine—ABCB1—prostate gland—prostate cancer	0.000377	0.0181	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Epirubicin—prostate cancer	0.00037	0.137	CbGdCrCtD
Amsacrine—TOP2A—Paclitaxel—Cabazitaxel—prostate cancer	0.000365	0.136	CbGdCrCtD
Amsacrine—CYP2D6—renal system—prostate cancer	0.000358	0.0172	CbGeAlD
Amsacrine—NCOA3—Idarubicin—Doxorubicin—prostate cancer	0.000342	0.127	CbGdCrCtD
Amsacrine—ABCB1—seminal vesicle—prostate cancer	0.000319	0.0153	CbGeAlD
Amsacrine—ABCB1—epithelium—prostate cancer	0.000277	0.0133	CbGeAlD
Amsacrine—KCNH2—lymph node—prostate cancer	0.000275	0.0132	CbGeAlD
Amsacrine—ABCB1—renal system—prostate cancer	0.000257	0.0123	CbGeAlD
Amsacrine—ABCB1—urethra—prostate cancer	0.000253	0.0121	CbGeAlD
Amsacrine—CYP2D6—testis—prostate cancer	0.000231	0.0111	CbGeAlD
Amsacrine—ABCB1—bone marrow—prostate cancer	0.000195	0.00933	CbGeAlD
Amsacrine—ABCB1—testis—prostate cancer	0.000166	0.00797	CbGeAlD
Amsacrine—TOP2A—Paclitaxel—Docetaxel—prostate cancer	0.000152	0.0563	CbGdCrCtD
Amsacrine—ABCB1—lymph node—prostate cancer	0.000121	0.00578	CbGeAlD
Amsacrine—TOP2A—Fulvestrant—Estradiol—prostate cancer	0.000111	0.0411	CbGdCrCtD
Amsacrine—TOP2A—Podofilox—Etoposide—prostate cancer	9.75e-05	0.0361	CbGdCrCtD
Amsacrine—TOP2A—Teniposide—Etoposide—prostate cancer	9.75e-05	0.0361	CbGdCrCtD
Amsacrine—TOP2A—Levorphanol—Estrone—prostate cancer	9.65e-05	0.0358	CbGdCrCtD
Amsacrine—TOP2A—Levorphanol—Estradiol—prostate cancer	7.32e-05	0.0271	CbGdCrCtD
Amsacrine—TOP2A—Methyltestosterone—Ethinyl Estradiol—prostate cancer	6.68e-05	0.0248	CbGdCrCtD
Amsacrine—TOP2A—Daunorubicin—Epirubicin—prostate cancer	5.08e-05	0.0188	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Epirubicin—prostate cancer	5.08e-05	0.0188	CbGdCrCtD
Amsacrine—TOP2A—Doxorubicin—Epirubicin—prostate cancer	5.08e-05	0.0188	CbGdCrCtD
Amsacrine—Anorexia—Etoposide—prostate cancer	4.79e-05	0.000381	CcSEcCtD
Amsacrine—Hypersensitivity—Estradiol—prostate cancer	4.78e-05	0.00038	CcSEcCtD
Amsacrine—Body temperature increased—Mitoxantrone—prostate cancer	4.78e-05	0.00038	CcSEcCtD
Amsacrine—Abdominal pain—Mitoxantrone—prostate cancer	4.78e-05	0.00038	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	4.78e-05	0.00038	CcSEcCtD
Amsacrine—Anaemia—Docetaxel—prostate cancer	4.73e-05	0.000376	CcSEcCtD
Amsacrine—Pancytopenia—Epirubicin—prostate cancer	4.71e-05	0.000374	CcSEcCtD
Amsacrine—TOP2A—Daunorubicin—Doxorubicin—prostate cancer	4.7e-05	0.0174	CbGdCrCtD
Amsacrine—TOP2A—Idarubicin—Doxorubicin—prostate cancer	4.7e-05	0.0174	CbGdCrCtD
Amsacrine—TOP2A—Epirubicin—Doxorubicin—prostate cancer	4.7e-05	0.0174	CbGdCrCtD
Amsacrine—Hypotension—Etoposide—prostate cancer	4.7e-05	0.000373	CcSEcCtD
Amsacrine—Vision blurred—Capecitabine—prostate cancer	4.67e-05	0.000371	CcSEcCtD
Amsacrine—Asthenia—Estradiol—prostate cancer	4.65e-05	0.00037	CcSEcCtD
Amsacrine—Angiopathy—Prednisone—prostate cancer	4.6e-05	0.000366	CcSEcCtD
Amsacrine—Dysphagia—Doxorubicin—prostate cancer	4.59e-05	0.000364	CcSEcCtD
Amsacrine—Leukopenia—Docetaxel—prostate cancer	4.58e-05	0.000364	CcSEcCtD
Amsacrine—Anaemia—Capecitabine—prostate cancer	4.58e-05	0.000364	CcSEcCtD
Amsacrine—Arrhythmia—Prednisone—prostate cancer	4.53e-05	0.00036	CcSEcCtD
Amsacrine—Paraesthesia—Etoposide—prostate cancer	4.51e-05	0.000359	CcSEcCtD
Amsacrine—Weight increased—Epirubicin—prostate cancer	4.51e-05	0.000358	CcSEcCtD
Amsacrine—Weight decreased—Epirubicin—prostate cancer	4.48e-05	0.000356	CcSEcCtD
Amsacrine—Dyspnoea—Etoposide—prostate cancer	4.48e-05	0.000356	CcSEcCtD
Amsacrine—Alopecia—Prednisone—prostate cancer	4.48e-05	0.000356	CcSEcCtD
Amsacrine—Hypersensitivity—Mitoxantrone—prostate cancer	4.45e-05	0.000354	CcSEcCtD
Amsacrine—Mental disorder—Prednisone—prostate cancer	4.44e-05	0.000353	CcSEcCtD
Amsacrine—Diarrhoea—Estradiol—prostate cancer	4.44e-05	0.000353	CcSEcCtD
Amsacrine—Leukopenia—Capecitabine—prostate cancer	4.44e-05	0.000352	CcSEcCtD
Amsacrine—Convulsion—Docetaxel—prostate cancer	4.44e-05	0.000352	CcSEcCtD
Amsacrine—Infestation NOS—Epirubicin—prostate cancer	4.42e-05	0.000351	CcSEcCtD
Amsacrine—Infestation—Epirubicin—prostate cancer	4.42e-05	0.000351	CcSEcCtD
Amsacrine—Malnutrition—Prednisone—prostate cancer	4.42e-05	0.000351	CcSEcCtD
Amsacrine—Decreased appetite—Etoposide—prostate cancer	4.37e-05	0.000347	CcSEcCtD
Amsacrine—Pancytopenia—Doxorubicin—prostate cancer	4.36e-05	0.000346	CcSEcCtD
Amsacrine—TOP2A—Norethindrone—Ethinyl Estradiol—prostate cancer	4.35e-05	0.0161	CbGdCrCtD
Amsacrine—Renal failure—Epirubicin—prostate cancer	4.34e-05	0.000345	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Etoposide—prostate cancer	4.34e-05	0.000345	CcSEcCtD
Amsacrine—Asthenia—Mitoxantrone—prostate cancer	4.34e-05	0.000345	CcSEcCtD
Amsacrine—Fatigue—Etoposide—prostate cancer	4.33e-05	0.000344	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	4.33e-05	0.000344	CcSEcCtD
Amsacrine—Jaundice—Epirubicin—prostate cancer	4.31e-05	0.000342	CcSEcCtD
Amsacrine—Stomatitis—Epirubicin—prostate cancer	4.31e-05	0.000342	CcSEcCtD
Amsacrine—Pain—Etoposide—prostate cancer	4.3e-05	0.000342	CcSEcCtD
Amsacrine—Dizziness—Estradiol—prostate cancer	4.29e-05	0.000341	CcSEcCtD
Amsacrine—Haematuria—Epirubicin—prostate cancer	4.21e-05	0.000335	CcSEcCtD
Amsacrine—Confusional state—Docetaxel—prostate cancer	4.21e-05	0.000335	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.19e-05	0.000333	CcSEcCtD
Amsacrine—Hepatobiliary disease—Epirubicin—prostate cancer	4.18e-05	0.000332	CcSEcCtD
Amsacrine—Weight increased—Doxorubicin—prostate cancer	4.17e-05	0.000332	CcSEcCtD
Amsacrine—Vision blurred—Prednisone—prostate cancer	4.16e-05	0.000331	CcSEcCtD
Amsacrine—Infection—Docetaxel—prostate cancer	4.15e-05	0.00033	CcSEcCtD
Amsacrine—Weight decreased—Doxorubicin—prostate cancer	4.15e-05	0.00033	CcSEcCtD
Amsacrine—Feeling abnormal—Etoposide—prostate cancer	4.14e-05	0.000329	CcSEcCtD
Amsacrine—Diarrhoea—Mitoxantrone—prostate cancer	4.14e-05	0.000329	CcSEcCtD
Amsacrine—Vomiting—Estradiol—prostate cancer	4.12e-05	0.000328	CcSEcCtD
Amsacrine—Agranulocytosis—Epirubicin—prostate cancer	4.12e-05	0.000328	CcSEcCtD
Amsacrine—Gastrointestinal pain—Etoposide—prostate cancer	4.11e-05	0.000327	CcSEcCtD
Amsacrine—Thrombocytopenia—Docetaxel—prostate cancer	4.09e-05	0.000325	CcSEcCtD
Amsacrine—Rash—Estradiol—prostate cancer	4.09e-05	0.000325	CcSEcCtD
Amsacrine—Infestation—Doxorubicin—prostate cancer	4.09e-05	0.000325	CcSEcCtD
Amsacrine—Infestation NOS—Doxorubicin—prostate cancer	4.09e-05	0.000325	CcSEcCtD
Amsacrine—Dermatitis—Estradiol—prostate cancer	4.09e-05	0.000325	CcSEcCtD
Amsacrine—Anaemia—Prednisone—prostate cancer	4.08e-05	0.000324	CcSEcCtD
Amsacrine—Confusional state—Capecitabine—prostate cancer	4.08e-05	0.000324	CcSEcCtD
Amsacrine—Tachycardia—Docetaxel—prostate cancer	4.08e-05	0.000324	CcSEcCtD
Amsacrine—Headache—Estradiol—prostate cancer	4.06e-05	0.000323	CcSEcCtD
Amsacrine—Skin disorder—Docetaxel—prostate cancer	4.06e-05	0.000322	CcSEcCtD
Amsacrine—Bradycardia—Epirubicin—prostate cancer	4.04e-05	0.000321	CcSEcCtD
Amsacrine—Renal failure—Doxorubicin—prostate cancer	4.02e-05	0.000319	CcSEcCtD
Amsacrine—Infection—Capecitabine—prostate cancer	4.02e-05	0.000319	CcSEcCtD
Amsacrine—Urticaria—Etoposide—prostate cancer	3.99e-05	0.000317	CcSEcCtD
Amsacrine—Haemoglobin—Epirubicin—prostate cancer	3.99e-05	0.000317	CcSEcCtD
Amsacrine—Jaundice—Doxorubicin—prostate cancer	3.99e-05	0.000317	CcSEcCtD
Amsacrine—Stomatitis—Doxorubicin—prostate cancer	3.99e-05	0.000317	CcSEcCtD
Amsacrine—Anorexia—Docetaxel—prostate cancer	3.98e-05	0.000316	CcSEcCtD
Amsacrine—Abdominal pain—Etoposide—prostate cancer	3.97e-05	0.000316	CcSEcCtD
Amsacrine—Body temperature increased—Etoposide—prostate cancer	3.97e-05	0.000316	CcSEcCtD
Amsacrine—Hepatitis—Epirubicin—prostate cancer	3.97e-05	0.000315	CcSEcCtD
Amsacrine—Haemorrhage—Epirubicin—prostate cancer	3.97e-05	0.000315	CcSEcCtD
Amsacrine—Thrombocytopenia—Capecitabine—prostate cancer	3.96e-05	0.000315	CcSEcCtD
Amsacrine—Tachycardia—Capecitabine—prostate cancer	3.95e-05	0.000314	CcSEcCtD
Amsacrine—Hypoaesthesia—Epirubicin—prostate cancer	3.95e-05	0.000314	CcSEcCtD
Amsacrine—Skin disorder—Capecitabine—prostate cancer	3.93e-05	0.000312	CcSEcCtD
Amsacrine—Urinary tract disorder—Epirubicin—prostate cancer	3.92e-05	0.000311	CcSEcCtD
Amsacrine—Hypotension—Docetaxel—prostate cancer	3.9e-05	0.00031	CcSEcCtD
Amsacrine—Haematuria—Doxorubicin—prostate cancer	3.9e-05	0.00031	CcSEcCtD
Amsacrine—Connective tissue disorder—Epirubicin—prostate cancer	3.9e-05	0.00031	CcSEcCtD
Amsacrine—Urethral disorder—Epirubicin—prostate cancer	3.89e-05	0.000309	CcSEcCtD
Amsacrine—Hepatobiliary disease—Doxorubicin—prostate cancer	3.87e-05	0.000307	CcSEcCtD
Amsacrine—Anorexia—Capecitabine—prostate cancer	3.86e-05	0.000306	CcSEcCtD
Amsacrine—Nausea—Estradiol—prostate cancer	3.85e-05	0.000306	CcSEcCtD
Amsacrine—Vomiting—Mitoxantrone—prostate cancer	3.84e-05	0.000305	CcSEcCtD
Amsacrine—Convulsion—Prednisone—prostate cancer	3.83e-05	0.000304	CcSEcCtD
Amsacrine—Agranulocytosis—Doxorubicin—prostate cancer	3.82e-05	0.000303	CcSEcCtD
Amsacrine—Rash—Mitoxantrone—prostate cancer	3.81e-05	0.000303	CcSEcCtD
Amsacrine—Dermatitis—Mitoxantrone—prostate cancer	3.81e-05	0.000302	CcSEcCtD
Amsacrine—Headache—Mitoxantrone—prostate cancer	3.79e-05	0.000301	CcSEcCtD
Amsacrine—Hypotension—Capecitabine—prostate cancer	3.78e-05	0.0003	CcSEcCtD
Amsacrine—Paraesthesia—Docetaxel—prostate cancer	3.75e-05	0.000298	CcSEcCtD
Amsacrine—Bradycardia—Doxorubicin—prostate cancer	3.74e-05	0.000297	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.73e-05	0.000297	CcSEcCtD
Amsacrine—Dyspnoea—Docetaxel—prostate cancer	3.73e-05	0.000296	CcSEcCtD
Amsacrine—Hypersensitivity—Etoposide—prostate cancer	3.7e-05	0.000294	CcSEcCtD
Amsacrine—Haemoglobin—Doxorubicin—prostate cancer	3.69e-05	0.000293	CcSEcCtD
Amsacrine—Cardiac disorder—Epirubicin—prostate cancer	3.68e-05	0.000292	CcSEcCtD
Amsacrine—Haemorrhage—Doxorubicin—prostate cancer	3.67e-05	0.000292	CcSEcCtD
Amsacrine—Hepatitis—Doxorubicin—prostate cancer	3.67e-05	0.000292	CcSEcCtD
Amsacrine—Hypoaesthesia—Doxorubicin—prostate cancer	3.65e-05	0.00029	CcSEcCtD
Amsacrine—Paraesthesia—Capecitabine—prostate cancer	3.63e-05	0.000289	CcSEcCtD
Amsacrine—Decreased appetite—Docetaxel—prostate cancer	3.63e-05	0.000289	CcSEcCtD
Amsacrine—Urinary tract disorder—Doxorubicin—prostate cancer	3.63e-05	0.000288	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Docetaxel—prostate cancer	3.61e-05	0.000287	CcSEcCtD
Amsacrine—Asthenia—Etoposide—prostate cancer	3.61e-05	0.000287	CcSEcCtD
Amsacrine—Connective tissue disorder—Doxorubicin—prostate cancer	3.61e-05	0.000287	CcSEcCtD
Amsacrine—Dyspnoea—Capecitabine—prostate cancer	3.61e-05	0.000287	CcSEcCtD
Amsacrine—Fatigue—Docetaxel—prostate cancer	3.6e-05	0.000286	CcSEcCtD
Amsacrine—Angiopathy—Epirubicin—prostate cancer	3.6e-05	0.000286	CcSEcCtD
Amsacrine—Urethral disorder—Doxorubicin—prostate cancer	3.6e-05	0.000286	CcSEcCtD
Amsacrine—Nausea—Mitoxantrone—prostate cancer	3.59e-05	0.000285	CcSEcCtD
Amsacrine—Infection—Prednisone—prostate cancer	3.58e-05	0.000284	CcSEcCtD
Amsacrine—Mediastinal disorder—Epirubicin—prostate cancer	3.58e-05	0.000284	CcSEcCtD
Amsacrine—Pain—Docetaxel—prostate cancer	3.57e-05	0.000284	CcSEcCtD
Amsacrine—Arrhythmia—Epirubicin—prostate cancer	3.54e-05	0.000282	CcSEcCtD
Amsacrine—Tachycardia—Prednisone—prostate cancer	3.52e-05	0.000279	CcSEcCtD
Amsacrine—Decreased appetite—Capecitabine—prostate cancer	3.52e-05	0.000279	CcSEcCtD
Amsacrine—Alopecia—Epirubicin—prostate cancer	3.51e-05	0.000278	CcSEcCtD
Amsacrine—Skin disorder—Prednisone—prostate cancer	3.5e-05	0.000278	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Capecitabine—prostate cancer	3.49e-05	0.000277	CcSEcCtD
Amsacrine—Fatigue—Capecitabine—prostate cancer	3.49e-05	0.000277	CcSEcCtD
Amsacrine—Mental disorder—Epirubicin—prostate cancer	3.48e-05	0.000276	CcSEcCtD
Amsacrine—TOP2A—Levonorgestrel—Ethinyl Estradiol—prostate cancer	3.46e-05	0.0128	CbGdCrCtD
Amsacrine—Pain—Capecitabine—prostate cancer	3.46e-05	0.000275	CcSEcCtD
Amsacrine—Malnutrition—Epirubicin—prostate cancer	3.45e-05	0.000274	CcSEcCtD
Amsacrine—Feeling abnormal—Docetaxel—prostate cancer	3.44e-05	0.000274	CcSEcCtD
Amsacrine—Diarrhoea—Etoposide—prostate cancer	3.44e-05	0.000273	CcSEcCtD
Amsacrine—Anorexia—Prednisone—prostate cancer	3.44e-05	0.000273	CcSEcCtD
Amsacrine—Gastrointestinal pain—Docetaxel—prostate cancer	3.42e-05	0.000271	CcSEcCtD
Amsacrine—Cardiac disorder—Doxorubicin—prostate cancer	3.41e-05	0.000271	CcSEcCtD
Amsacrine—Feeling abnormal—Capecitabine—prostate cancer	3.33e-05	0.000265	CcSEcCtD
Amsacrine—Angiopathy—Doxorubicin—prostate cancer	3.33e-05	0.000265	CcSEcCtD
Amsacrine—Dizziness—Etoposide—prostate cancer	3.32e-05	0.000264	CcSEcCtD
Amsacrine—Gastrointestinal pain—Capecitabine—prostate cancer	3.31e-05	0.000263	CcSEcCtD
Amsacrine—Mediastinal disorder—Doxorubicin—prostate cancer	3.31e-05	0.000263	CcSEcCtD
Amsacrine—Abdominal pain—Docetaxel—prostate cancer	3.3e-05	0.000262	CcSEcCtD
Amsacrine—Body temperature increased—Docetaxel—prostate cancer	3.3e-05	0.000262	CcSEcCtD
Amsacrine—Arrhythmia—Doxorubicin—prostate cancer	3.28e-05	0.00026	CcSEcCtD
Amsacrine—Vision blurred—Epirubicin—prostate cancer	3.25e-05	0.000259	CcSEcCtD
Amsacrine—Alopecia—Doxorubicin—prostate cancer	3.24e-05	0.000258	CcSEcCtD
Amsacrine—Paraesthesia—Prednisone—prostate cancer	3.24e-05	0.000257	CcSEcCtD
Amsacrine—Mental disorder—Doxorubicin—prostate cancer	3.22e-05	0.000255	CcSEcCtD
Amsacrine—Urticaria—Capecitabine—prostate cancer	3.21e-05	0.000255	CcSEcCtD
Amsacrine—Abdominal pain—Capecitabine—prostate cancer	3.2e-05	0.000254	CcSEcCtD
Amsacrine—Body temperature increased—Capecitabine—prostate cancer	3.2e-05	0.000254	CcSEcCtD
Amsacrine—Vomiting—Etoposide—prostate cancer	3.2e-05	0.000254	CcSEcCtD
Amsacrine—Malnutrition—Doxorubicin—prostate cancer	3.2e-05	0.000254	CcSEcCtD
Amsacrine—Anaemia—Epirubicin—prostate cancer	3.19e-05	0.000254	CcSEcCtD
Amsacrine—Rash—Etoposide—prostate cancer	3.17e-05	0.000252	CcSEcCtD
Amsacrine—Dermatitis—Etoposide—prostate cancer	3.17e-05	0.000252	CcSEcCtD
Amsacrine—Headache—Etoposide—prostate cancer	3.15e-05	0.00025	CcSEcCtD
Amsacrine—Decreased appetite—Prednisone—prostate cancer	3.13e-05	0.000249	CcSEcCtD
Amsacrine—Fatigue—Prednisone—prostate cancer	3.11e-05	0.000247	CcSEcCtD
Amsacrine—Leukopenia—Epirubicin—prostate cancer	3.09e-05	0.000246	CcSEcCtD
Amsacrine—Hypersensitivity—Docetaxel—prostate cancer	3.08e-05	0.000245	CcSEcCtD
Amsacrine—Vision blurred—Doxorubicin—prostate cancer	3.01e-05	0.000239	CcSEcCtD
Amsacrine—Asthenia—Docetaxel—prostate cancer	3e-05	0.000238	CcSEcCtD
Amsacrine—Convulsion—Epirubicin—prostate cancer	2.99e-05	0.000238	CcSEcCtD
Amsacrine—Nausea—Etoposide—prostate cancer	2.99e-05	0.000237	CcSEcCtD
Amsacrine—Hypersensitivity—Capecitabine—prostate cancer	2.98e-05	0.000237	CcSEcCtD
Amsacrine—Feeling abnormal—Prednisone—prostate cancer	2.97e-05	0.000236	CcSEcCtD
Amsacrine—Anaemia—Doxorubicin—prostate cancer	2.95e-05	0.000235	CcSEcCtD
Amsacrine—Gastrointestinal pain—Prednisone—prostate cancer	2.95e-05	0.000234	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.92e-05	0.000232	CcSEcCtD
Amsacrine—Asthenia—Capecitabine—prostate cancer	2.9e-05	0.000231	CcSEcCtD
Amsacrine—Urticaria—Prednisone—prostate cancer	2.86e-05	0.000227	CcSEcCtD
Amsacrine—Leukopenia—Doxorubicin—prostate cancer	2.86e-05	0.000227	CcSEcCtD
Amsacrine—Diarrhoea—Docetaxel—prostate cancer	2.86e-05	0.000227	CcSEcCtD
Amsacrine—Abdominal pain—Prednisone—prostate cancer	2.85e-05	0.000226	CcSEcCtD
Amsacrine—Body temperature increased—Prednisone—prostate cancer	2.85e-05	0.000226	CcSEcCtD
Amsacrine—Confusional state—Epirubicin—prostate cancer	2.84e-05	0.000226	CcSEcCtD
Amsacrine—Infection—Epirubicin—prostate cancer	2.8e-05	0.000222	CcSEcCtD
Amsacrine—Convulsion—Doxorubicin—prostate cancer	2.77e-05	0.00022	CcSEcCtD
Amsacrine—Diarrhoea—Capecitabine—prostate cancer	2.77e-05	0.00022	CcSEcCtD
Amsacrine—Dizziness—Docetaxel—prostate cancer	2.76e-05	0.00022	CcSEcCtD
Amsacrine—Thrombocytopenia—Epirubicin—prostate cancer	2.76e-05	0.000219	CcSEcCtD
Amsacrine—Tachycardia—Epirubicin—prostate cancer	2.75e-05	0.000219	CcSEcCtD
Amsacrine—Skin disorder—Epirubicin—prostate cancer	2.74e-05	0.000217	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.7e-05	0.000215	CcSEcCtD
Amsacrine—Anorexia—Epirubicin—prostate cancer	2.69e-05	0.000213	CcSEcCtD
Amsacrine—Dizziness—Capecitabine—prostate cancer	2.68e-05	0.000213	CcSEcCtD
Amsacrine—Vomiting—Docetaxel—prostate cancer	2.66e-05	0.000211	CcSEcCtD
Amsacrine—Hypersensitivity—Prednisone—prostate cancer	2.66e-05	0.000211	CcSEcCtD
Amsacrine—Rash—Docetaxel—prostate cancer	2.63e-05	0.000209	CcSEcCtD
Amsacrine—Hypotension—Epirubicin—prostate cancer	2.63e-05	0.000209	CcSEcCtD
Amsacrine—Dermatitis—Docetaxel—prostate cancer	2.63e-05	0.000209	CcSEcCtD
Amsacrine—Confusional state—Doxorubicin—prostate cancer	2.63e-05	0.000209	CcSEcCtD
Amsacrine—Headache—Docetaxel—prostate cancer	2.62e-05	0.000208	CcSEcCtD
Amsacrine—Infection—Doxorubicin—prostate cancer	2.59e-05	0.000206	CcSEcCtD
Amsacrine—Asthenia—Prednisone—prostate cancer	2.59e-05	0.000205	CcSEcCtD
Amsacrine—Vomiting—Capecitabine—prostate cancer	2.57e-05	0.000204	CcSEcCtD
Amsacrine—Thrombocytopenia—Doxorubicin—prostate cancer	2.55e-05	0.000203	CcSEcCtD
Amsacrine—Rash—Capecitabine—prostate cancer	2.55e-05	0.000203	CcSEcCtD
Amsacrine—Dermatitis—Capecitabine—prostate cancer	2.55e-05	0.000202	CcSEcCtD
Amsacrine—Tachycardia—Doxorubicin—prostate cancer	2.55e-05	0.000202	CcSEcCtD
Amsacrine—Headache—Capecitabine—prostate cancer	2.53e-05	0.000201	CcSEcCtD
Amsacrine—Skin disorder—Doxorubicin—prostate cancer	2.53e-05	0.000201	CcSEcCtD
Amsacrine—Paraesthesia—Epirubicin—prostate cancer	2.53e-05	0.000201	CcSEcCtD
Amsacrine—Dyspnoea—Epirubicin—prostate cancer	2.51e-05	0.0002	CcSEcCtD
Amsacrine—Anorexia—Doxorubicin—prostate cancer	2.49e-05	0.000197	CcSEcCtD
Amsacrine—Nausea—Docetaxel—prostate cancer	2.48e-05	0.000197	CcSEcCtD
Amsacrine—Diarrhoea—Prednisone—prostate cancer	2.47e-05	0.000196	CcSEcCtD
Amsacrine—Decreased appetite—Epirubicin—prostate cancer	2.45e-05	0.000195	CcSEcCtD
Amsacrine—Hypotension—Doxorubicin—prostate cancer	2.44e-05	0.000194	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.43e-05	0.000193	CcSEcCtD
Amsacrine—Fatigue—Epirubicin—prostate cancer	2.43e-05	0.000193	CcSEcCtD
Amsacrine—Pain—Epirubicin—prostate cancer	2.41e-05	0.000191	CcSEcCtD
Amsacrine—Nausea—Capecitabine—prostate cancer	2.4e-05	0.000191	CcSEcCtD
Amsacrine—Dizziness—Prednisone—prostate cancer	2.38e-05	0.000189	CcSEcCtD
Amsacrine—TOP2A—Methyltestosterone—Prednisone—prostate cancer	2.35e-05	0.0087	CbGdCrCtD
Amsacrine—Paraesthesia—Doxorubicin—prostate cancer	2.34e-05	0.000186	CcSEcCtD
Amsacrine—Dyspnoea—Doxorubicin—prostate cancer	2.33e-05	0.000185	CcSEcCtD
Amsacrine—Feeling abnormal—Epirubicin—prostate cancer	2.32e-05	0.000184	CcSEcCtD
Amsacrine—Gastrointestinal pain—Epirubicin—prostate cancer	2.3e-05	0.000183	CcSEcCtD
Amsacrine—Vomiting—Prednisone—prostate cancer	2.29e-05	0.000182	CcSEcCtD
Amsacrine—Rash—Prednisone—prostate cancer	2.27e-05	0.00018	CcSEcCtD
Amsacrine—Dermatitis—Prednisone—prostate cancer	2.27e-05	0.00018	CcSEcCtD
Amsacrine—Decreased appetite—Doxorubicin—prostate cancer	2.27e-05	0.00018	CcSEcCtD
Amsacrine—Headache—Prednisone—prostate cancer	2.26e-05	0.000179	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.25e-05	0.000179	CcSEcCtD
Amsacrine—Fatigue—Doxorubicin—prostate cancer	2.25e-05	0.000179	CcSEcCtD
Amsacrine—Urticaria—Epirubicin—prostate cancer	2.24e-05	0.000178	CcSEcCtD
Amsacrine—Pain—Doxorubicin—prostate cancer	2.23e-05	0.000177	CcSEcCtD
Amsacrine—Abdominal pain—Epirubicin—prostate cancer	2.23e-05	0.000177	CcSEcCtD
Amsacrine—Body temperature increased—Epirubicin—prostate cancer	2.23e-05	0.000177	CcSEcCtD
Amsacrine—Feeling abnormal—Doxorubicin—prostate cancer	2.15e-05	0.000171	CcSEcCtD
Amsacrine—Nausea—Prednisone—prostate cancer	2.14e-05	0.00017	CcSEcCtD
Amsacrine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.13e-05	0.000169	CcSEcCtD
Amsacrine—Hypersensitivity—Epirubicin—prostate cancer	2.08e-05	0.000165	CcSEcCtD
Amsacrine—Urticaria—Doxorubicin—prostate cancer	2.07e-05	0.000165	CcSEcCtD
Amsacrine—Abdominal pain—Doxorubicin—prostate cancer	2.06e-05	0.000164	CcSEcCtD
Amsacrine—Body temperature increased—Doxorubicin—prostate cancer	2.06e-05	0.000164	CcSEcCtD
Amsacrine—Asthenia—Epirubicin—prostate cancer	2.02e-05	0.000161	CcSEcCtD
Amsacrine—Diarrhoea—Epirubicin—prostate cancer	1.93e-05	0.000153	CcSEcCtD
Amsacrine—Hypersensitivity—Doxorubicin—prostate cancer	1.92e-05	0.000153	CcSEcCtD
Amsacrine—Asthenia—Doxorubicin—prostate cancer	1.87e-05	0.000149	CcSEcCtD
Amsacrine—Dizziness—Epirubicin—prostate cancer	1.86e-05	0.000148	CcSEcCtD
Amsacrine—Vomiting—Epirubicin—prostate cancer	1.79e-05	0.000142	CcSEcCtD
Amsacrine—Diarrhoea—Doxorubicin—prostate cancer	1.78e-05	0.000142	CcSEcCtD
Amsacrine—Rash—Epirubicin—prostate cancer	1.78e-05	0.000141	CcSEcCtD
Amsacrine—Dermatitis—Epirubicin—prostate cancer	1.78e-05	0.000141	CcSEcCtD
Amsacrine—Headache—Epirubicin—prostate cancer	1.77e-05	0.00014	CcSEcCtD
Amsacrine—Dizziness—Doxorubicin—prostate cancer	1.72e-05	0.000137	CcSEcCtD
Amsacrine—Nausea—Epirubicin—prostate cancer	1.67e-05	0.000133	CcSEcCtD
Amsacrine—Vomiting—Doxorubicin—prostate cancer	1.66e-05	0.000132	CcSEcCtD
Amsacrine—Rash—Doxorubicin—prostate cancer	1.64e-05	0.000131	CcSEcCtD
Amsacrine—Dermatitis—Doxorubicin—prostate cancer	1.64e-05	0.00013	CcSEcCtD
Amsacrine—Headache—Doxorubicin—prostate cancer	1.63e-05	0.00013	CcSEcCtD
Amsacrine—Nausea—Doxorubicin—prostate cancer	1.55e-05	0.000123	CcSEcCtD
Amsacrine—CYP2D6—Metabolism—GRHL1—prostate cancer	1.05e-05	0.00014	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PSAT1—prostate cancer	1.05e-05	0.00014	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CBR1—prostate cancer	1.05e-05	0.00014	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TST—prostate cancer	1.05e-05	0.00014	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UGT2B17—prostate cancer	1.04e-05	0.000138	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GRHPR—prostate cancer	1.04e-05	0.000138	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UGT2B15—prostate cancer	1.04e-05	0.000138	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CKMT2—prostate cancer	1.04e-05	0.000138	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MDM2—prostate cancer	1.04e-05	0.000138	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	1.03e-05	0.000138	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CCND1—prostate cancer	1.01e-05	0.000134	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	1e-05	0.000133	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	9.93e-06	0.000132	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	9.91e-06	0.000132	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CB—prostate cancer	9.89e-06	0.000131	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UGT2B15—prostate cancer	9.81e-06	0.00013	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UGT2B17—prostate cancer	9.81e-06	0.00013	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GRHPR—prostate cancer	9.81e-06	0.00013	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CKMT2—prostate cancer	9.81e-06	0.00013	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTGS2—prostate cancer	9.8e-06	0.00013	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SULT2B1—prostate cancer	9.79e-06	0.00013	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AOX1—prostate cancer	9.79e-06	0.00013	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NAGLU—prostate cancer	9.79e-06	0.00013	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PGAM2—prostate cancer	9.79e-06	0.00013	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MBTPS1—prostate cancer	9.79e-06	0.00013	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—RFK—prostate cancer	9.79e-06	0.00013	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM3—prostate cancer	9.79e-06	0.00013	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—CDKN1A—prostate cancer	9.78e-06	0.00013	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN1B—prostate cancer	9.48e-06	0.000126	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—GNG5—prostate cancer	9.44e-06	0.000125	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—EP300—prostate cancer	9.31e-06	0.000124	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	9.29e-06	0.000123	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NAT1—prostate cancer	9.28e-06	0.000123	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP3A43—prostate cancer	9.28e-06	0.000123	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AMACR—prostate cancer	9.28e-06	0.000123	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SRD5A2—prostate cancer	9.28e-06	0.000123	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—DEGS1—prostate cancer	9.28e-06	0.000123	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—RFK—prostate cancer	9.22e-06	0.000123	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AOX1—prostate cancer	9.22e-06	0.000123	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PGAM2—prostate cancer	9.22e-06	0.000123	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM3—prostate cancer	9.22e-06	0.000123	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SULT2B1—prostate cancer	9.22e-06	0.000123	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NAGLU—prostate cancer	9.22e-06	0.000123	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MBTPS1—prostate cancer	9.22e-06	0.000123	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	9.18e-06	0.000122	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CCND1—prostate cancer	9.04e-06	0.00012	CbGpPWpGaD
Amsacrine—ABCB1—HIF-1-alpha transcription factor network—AKT1—prostate cancer	8.95e-06	0.000119	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	8.87e-06	0.000118	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSD17B1—prostate cancer	8.85e-06	0.000118	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—CDKN1A—prostate cancer	8.74e-06	0.000116	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP3A43—prostate cancer	8.74e-06	0.000116	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AMACR—prostate cancer	8.74e-06	0.000116	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—DEGS1—prostate cancer	8.74e-06	0.000116	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NAT1—prostate cancer	8.74e-06	0.000116	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SRD5A2—prostate cancer	8.74e-06	0.000116	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PTEN—prostate cancer	8.55e-06	0.000114	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	8.44e-06	0.000112	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD17B1—prostate cancer	8.34e-06	0.000111	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—EP300—prostate cancer	8.32e-06	0.000111	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—EP300—prostate cancer	8.15e-06	0.000108	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle, Mitotic—MYC—prostate cancer	8.11e-06	0.000108	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	8.05e-06	0.000107	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	8.01e-06	0.000106	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	7.89e-06	0.000105	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—B4GALT4—prostate cancer	7.89e-06	0.000105	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HPGD—prostate cancer	7.89e-06	0.000105	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	7.78e-06	0.000103	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	7.61e-06	0.000101	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	7.59e-06	0.000101	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—B4GALT4—prostate cancer	7.43e-06	9.88e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HPGD—prostate cancer	7.43e-06	9.88e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TNFRSF21—prostate cancer	7.42e-06	9.85e-05	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—MYC—prostate cancer	7.25e-06	9.63e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	7.24e-06	9.62e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP7B1—prostate cancer	7.21e-06	9.59e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTAP—prostate cancer	7.21e-06	9.59e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	7.21e-06	9.58e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	7.06e-06	9.39e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SULT1E1—prostate cancer	7.03e-06	9.34e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SRD5A1—prostate cancer	7.03e-06	9.34e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TNFRSF21—prostate cancer	6.99e-06	9.29e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	6.88e-06	9.14e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	6.81e-06	9.05e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTAP—prostate cancer	6.8e-06	9.03e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP7B1—prostate cancer	6.8e-06	9.03e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ACSL4—prostate cancer	6.71e-06	8.91e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSD17B3—prostate cancer	6.71e-06	8.91e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	6.65e-06	8.84e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	6.64e-06	8.82e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SULT1E1—prostate cancer	6.63e-06	8.8e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SRD5A1—prostate cancer	6.63e-06	8.8e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ARG2—prostate cancer	6.43e-06	8.54e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PHGDH—prostate cancer	6.43e-06	8.54e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UMPS—prostate cancer	6.43e-06	8.54e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	6.4e-06	8.5e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	6.33e-06	8.41e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD17B3—prostate cancer	6.32e-06	8.4e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ACSL4—prostate cancer	6.32e-06	8.4e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LDHB—prostate cancer	6.31e-06	8.38e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP3A5—prostate cancer	6.19e-06	8.22e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	6.15e-06	8.18e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	6.08e-06	8.08e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UMPS—prostate cancer	6.06e-06	8.05e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PHGDH—prostate cancer	6.06e-06	8.05e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ARG2—prostate cancer	6.06e-06	8.05e-05	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—PIK3CA—prostate cancer	6.03e-06	8.01e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	5.99e-06	7.97e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PDHA1—prostate cancer	5.98e-06	7.94e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TCN2—prostate cancer	5.98e-06	7.94e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—UCP3—prostate cancer	5.98e-06	7.94e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA3—prostate cancer	5.98e-06	7.94e-05	CbGpPWpGaD
Amsacrine—TOP2A—Cell Cycle—TP53—prostate cancer	5.95e-06	7.91e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LDHB—prostate cancer	5.94e-06	7.9e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP3A5—prostate cancer	5.83e-06	7.75e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSD3B1—prostate cancer	5.7e-06	7.58e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC22A3—prostate cancer	5.7e-06	7.58e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PDHA1—prostate cancer	5.63e-06	7.48e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA3—prostate cancer	5.63e-06	7.48e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—UCP3—prostate cancer	5.63e-06	7.48e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TCN2—prostate cancer	5.63e-06	7.48e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	5.52e-06	7.33e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	5.5e-06	7.31e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA4—prostate cancer	5.47e-06	7.26e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TBXAS1—prostate cancer	5.47e-06	7.26e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	5.39e-06	7.17e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD3B1—prostate cancer	5.37e-06	7.14e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC22A3—prostate cancer	5.37e-06	7.14e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA2—prostate cancer	5.33e-06	7.08e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ABCG5—prostate cancer	5.26e-06	6.99e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SULT1A1—prostate cancer	5.26e-06	6.99e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA4—prostate cancer	5.15e-06	6.85e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TBXAS1—prostate cancer	5.15e-06	6.85e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTA1—prostate cancer	5.14e-06	6.83e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	5.1e-06	6.77e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HSD3B2—prostate cancer	5.08e-06	6.75e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTO1—prostate cancer	5.08e-06	6.75e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NAT2—prostate cancer	5.08e-06	6.75e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA2—prostate cancer	5.02e-06	6.67e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ABCG5—prostate cancer	4.96e-06	6.59e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SULT1A1—prostate cancer	4.96e-06	6.59e-05	CbGpPWpGaD
Amsacrine—NCOA3—Metabolism—AKT1—prostate cancer	4.93e-06	6.55e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PLCB2—prostate cancer	4.87e-06	6.47e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LRP2—prostate cancer	4.87e-06	6.47e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2C18—prostate cancer	4.87e-06	6.47e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTA1—prostate cancer	4.84e-06	6.44e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTO1—prostate cancer	4.79e-06	6.36e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HSD3B2—prostate cancer	4.79e-06	6.36e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NAT2—prostate cancer	4.79e-06	6.36e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—P4HB—prostate cancer	4.78e-06	6.35e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	4.68e-06	6.22e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC22A1—prostate cancer	4.65e-06	6.18e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	4.65e-06	6.17e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PLCB2—prostate cancer	4.59e-06	6.1e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LRP2—prostate cancer	4.59e-06	6.1e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2C18—prostate cancer	4.59e-06	6.1e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SULT2A1—prostate cancer	4.53e-06	6.02e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	4.53e-06	6.02e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—P4HB—prostate cancer	4.5e-06	5.98e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MED12—prostate cancer	4.46e-06	5.92e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GNG5—prostate cancer	4.42e-06	5.88e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC22A1—prostate cancer	4.38e-06	5.82e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SULT2A1—prostate cancer	4.27e-06	5.67e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOA3—prostate cancer	4.26e-06	5.66e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MED12—prostate cancer	4.2e-06	5.58e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GNG5—prostate cancer	4.17e-06	5.54e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—HPGDS—prostate cancer	4.06e-06	5.4e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2C19—prostate cancer	4.04e-06	5.37e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOA3—prostate cancer	4.01e-06	5.33e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ACHE—prostate cancer	3.94e-06	5.24e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTT1—prostate cancer	3.94e-06	5.24e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2A6—prostate cancer	3.9e-06	5.18e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—HPGDS—prostate cancer	3.83e-06	5.09e-05	CbGpPWpGaD
Amsacrine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	3.82e-06	5.08e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2C19—prostate cancer	3.81e-06	5.06e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKR1C3—prostate cancer	3.79e-06	5.04e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PRKACB—prostate cancer	3.77e-06	5.01e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP17A1—prostate cancer	3.73e-06	4.96e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTT1—prostate cancer	3.71e-06	4.93e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ACHE—prostate cancer	3.71e-06	4.93e-05	CbGpPWpGaD
Amsacrine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.69e-06	4.9e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2A6—prostate cancer	3.67e-06	4.88e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKR1C3—prostate cancer	3.57e-06	4.75e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOA2—prostate cancer	3.55e-06	4.72e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PRKACB—prostate cancer	3.55e-06	4.72e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP17A1—prostate cancer	3.52e-06	4.67e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—SLC5A5—prostate cancer	3.39e-06	4.51e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOA2—prostate cancer	3.35e-06	4.45e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP2E1—prostate cancer	3.31e-06	4.4e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NQO1—prostate cancer	3.28e-06	4.35e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TH—prostate cancer	3.23e-06	4.29e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—SLC5A5—prostate cancer	3.2e-06	4.25e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP3A4—prostate cancer	3.19e-06	4.24e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1B1—prostate cancer	3.14e-06	4.17e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP2E1—prostate cancer	3.12e-06	4.15e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NQO1—prostate cancer	3.09e-06	4.1e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TH—prostate cancer	3.04e-06	4.04e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GGT1—prostate cancer	3.04e-06	4.04e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP3A4—prostate cancer	3.01e-06	4e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NCOA1—prostate cancer	3e-06	3.98e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.96e-06	3.93e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP19A1—prostate cancer	2.95e-06	3.92e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GGT1—prostate cancer	2.87e-06	3.81e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—RXRA—prostate cancer	2.85e-06	3.79e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.82e-06	3.75e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.78e-06	3.7e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—COMT—prostate cancer	2.74e-06	3.65e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTP1—prostate cancer	2.73e-06	3.63e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ITPR1—prostate cancer	2.69e-06	3.57e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—RXRA—prostate cancer	2.69e-06	3.57e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—COMT—prostate cancer	2.59e-06	3.44e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTP1—prostate cancer	2.57e-06	3.42e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—TYMS—prostate cancer	2.54e-06	3.37e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ITPR1—prostate cancer	2.53e-06	3.37e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—GSTM1—prostate cancer	2.51e-06	3.34e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—LPL—prostate cancer	2.46e-06	3.27e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—TYMS—prostate cancer	2.39e-06	3.18e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CYP1A1—prostate cancer	2.38e-06	3.16e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—GSTM1—prostate cancer	2.37e-06	3.14e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—ERCC2—prostate cancer	2.36e-06	3.14e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—LPL—prostate cancer	2.32e-06	3.09e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.24e-06	2.98e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—ERCC2—prostate cancer	2.22e-06	2.96e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—MTHFR—prostate cancer	2.22e-06	2.95e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PPARA—prostate cancer	2.18e-06	2.89e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—MTHFR—prostate cancer	2.09e-06	2.78e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PPARA—prostate cancer	2.05e-06	2.73e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CAV1—prostate cancer	2.05e-06	2.72e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CAV1—prostate cancer	1.93e-06	2.56e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CG—prostate cancer	1.86e-06	2.48e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—INS—prostate cancer	1.76e-06	2.34e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.76e-06	2.33e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—CREBBP—prostate cancer	1.73e-06	2.3e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—INS—prostate cancer	1.66e-06	2.21e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CD—prostate cancer	1.64e-06	2.18e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.63e-06	2.16e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—NOS3—prostate cancer	1.55e-06	2.06e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.54e-06	2.05e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—NOS3—prostate cancer	1.46e-06	1.94e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.43e-06	1.9e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTGS2—prostate cancer	1.42e-06	1.88e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.35e-06	1.79e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.33e-06	1.77e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PTEN—prostate cancer	1.23e-06	1.64e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—EP300—prostate cancer	1.18e-06	1.56e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PTEN—prostate cancer	1.16e-06	1.55e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—EP300—prostate cancer	1.11e-06	1.47e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—PIK3CA—prostate cancer	8.71e-07	1.16e-05	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—PIK3CA—prostate cancer	8.21e-07	1.09e-05	CbGpPWpGaD
Amsacrine—ABCB1—Metabolism—AKT1—prostate cancer	7.11e-07	9.45e-06	CbGpPWpGaD
Amsacrine—CYP2D6—Metabolism—AKT1—prostate cancer	6.7e-07	8.91e-06	CbGpPWpGaD
